The Global Neurosyphilis Market is growing steadily and is expected to continue its growth during the forecast period. Global Neurosyphilis Market is expected to grow at the CAGR of ~3.9% during the forecast period and is estimated to reach USD 957.4 million by 2023.
Neurosyphilis is the infection of spinal cord and brain. It is most common in an individual who have untreated syphilis for long period of time. This is mainly caused due to bacteria called Treponema pallidum. This is the bacteria which causes syphilis. After getting infected with syphilis for the first time, there are chances of neurosyphilis after 10-20 years later.
The major symptoms of neurosyphilis are blindness, abnormal walk, confusion, depression, dementia, headache, irritability, incontinence, poor concentration, numbness in the toes, feet, or legs, seizures, tremors, stiff neck, visual disturbances, and weakness. There are possibility of no symptoms of neurosyphilis. Out of all types of neurosyphilis, asymptomatic neurosyphilis is the most common type.
Considering the market scenario of global neurosyphilis, increasing funding for research, clinical trials, and new product development are driving the growth for the market. Government and companies are investing large amount of money to derive effective cure for neurosyphilis.
Adoption of technologically advanced diagnostic medical devices are another important driver for the market. Some other factors like increasing awareness, rising demand from emerging markets, government support to improve public healthcare, and changing healthcare practices are also major factors for the market growth.
Access Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4021 .
Major players in Neurosyphilis Market:
There are plenty of large and small market players which operate in this market:
- Abbott (US),
- Bayer AG (Germany),
- Eli Lilly and Company (US),
- GlaxoSmithKline plc. (UK),
- Novartis AG (Switzerland),
- Pfizer Inc. (US),
- Sanofi (France)
Considering the global scenario of the neurosyphilis market, there are four main regions, America, Europe, Asia Pacific, and Middle East & Africa.
America is the largest market for neurosyphilis. The Americas mainly include North America and Latin America. North America is holding the largest market share in which US is dominating this market. Due to advanced diagnostic and treatment facilities, funding for research, clinical trials and new drugs and therapy development, and rapid adoption of new therapies, North America region is dominating the global neurosyphilis market. European region is the second important market, especially West European countries are dominating this region.
Eastern European countries are also showing significant growth in this market. Asia Pacific market is witnessing rapid growth due to increasing incidence and awareness of neurosyphilis, increasing healthcare expenditure and government initiative to increase awareness as well as to provide affordable healthcare.
Get Attractive Discount @ https://www.marketresearchfuture.com/check-discount/4021 .
Talking about the market scenario of Middle East & Africa, this region is expected to grow slower than global average during the forecast period due to various factors such as increasing lack of knowledge, limited access to the required healthcare facilities, availability of required products are restricting the growth of this market etc.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –